Skip to content

Search

Our services

CliniKids provides therapy support and individualised programs to help children and families to reach their full potential.

Our service model

CliniKids is putting the ‘evidence’ in evidence-based practice by providing families access to the best scientific-backed therapies as quickly as possible so that all autistic children have the chance to reach their full potential.

What the autistic community wants you to know about autism

For World Autism Acceptance Day, we asked our clients, their families and the community to tell us what they would like people to know about autism. Senior Speech Pathologist Sally Grauaug compiled their ideas and feedback into this blog.

Bathtime can mean more than just getting clean!

In this new blog, Speech Pathology Lead Aria May explains how bathtime is a great opportunity to support social communication with your child.

Our Locations

At The Kids Research Institute Australia, we have a dedicated and diverse team of over 1,000 staff, students and honorary researchers.

WA Kids Cancer Centre

The WA Kids Cancer Centre brings together clinicians and researchers working together to defeat childhood cancer.

Why timing matters: How tumours respond to immunotherapy treatments over time

Researchers have identified key differences between cancers that respond to immunotherapy and those that do not.

WA children with most aggressive cancers to benefit from Australian-first personalised medicine clinical trial

Personalised medicine for childhood cancers in West Australia is a step closer thanks to the Zero Childhood Cancer program’s state clinical trial launched today

New clinical trial to improve outcomes for babies with leukaemia

The Australian arm of an international clinical trial looking at improved treatments for young babies with leukaemia has been awarded funding from the MRFF.

Bone density treatment found to slow the progression of leukaemia

The Kids Research Institute Australia researchers may have unlocked a vital key to reducing the progression of leukaemia in children, potentially prompting a change in thinking around the best way to target treatment.